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Abstract
 
To determine the function of immunoglobulin (Ig)
 
 
 
 immunoreceptor tyrosine–based activa-
tion motif (ITAM) phosphorylation, we generated mice in which Ig
 
 
 
 ITAM tyrosines were
replaced by phenylalanines (
 
Ig
 
 
 
FF/FF
 
). 
 
Ig
 
 
 
FF/FF 
 
mice had a specific reduction of B1 and marginal
zone B cells, whereas B2 cell development appeared to be normal, except that 
 
 
 
1 light chain
usage was increased. The mutants responded less efficiently to T cell–dependent antigens,
whereas T cell–independent responses were unaffected. Upon B cell receptor ligation, the cells
exhibited heightened calcium flux, weaker Lyn and Syk tyrosine phosphorylation, and phos-
phorylation of Ig
 
 
 
 non-ITAM tyrosines. Strikingly, when the Ig
 
 
 
 ITAM mutation was com-
bined with a truncation of Ig
 
 
 
, B cell development was completely blocked at the pro-B cell
stage, indicating a crucial role of ITAM phosphorylation in B cell development.
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Introduction
 
B cell development is a highly ordered and controlled pro-
cess allowing the formation of a diverse repertoire of B cell
receptor (BCR)
 
*
 
 antigen specificities. Dependent on the
developmental status and the microenvironment of the B
cell, the strength and quality of BCR transmitted signals
control survival, differentiation, and proliferation (1, 2).
The BCR is a multimeric protein complex consisting of
an antigen binding module that is noncovalently associated
with one signal-transducing heterodimer of Ig
 
 
 
 (CD79a,
mb-1) and Ig
 
 
 
 (CD79b, B29) (3). An early and essential
feature of the signaling cascade is phosphorylation of the
tyrosine residues within immunoreceptor tyrosine–based
activation motif (ITAM) by Src family protein tyrosine ki-
nases (PTKs; references 4, 5, and 6). The phosphorylated
ITAMs are thought to serve as docking sites for Src homol-
ogy 2 (SH2) domain–containing proteins. For instance,
dual phosphorylation of the BCR ITAMs allows high af-
finity association of the tandem SH2 domain–containing
kinase Syk. Binding of Syk to ITAM leads to its phosphor-
ylation and activation which in turn leads to phosphoryla-
tion of downstream cellular substrates. Ig
 
 
 
 and Ig
 
 
 
 both
contain single ITAMs that potentially confer distinct signal-
ing functions. In support of this idea, several proteins have
been shown to associate differentially with either Ig
 
 
 
 or
Ig
 
 
 
 (7, 8). In transfection experiments using chimeric mol-
ecules, isolated cytoplasmic domains of either Ig
 
 
 
 or Ig
 
 
 
were both capable of mediating the mobilization of cal-
cium and tyrosine phosphorylation of cellular molecules.
These signaling capacities were critically dependent on
ITAM phosphorylation. Further data suggest that Ig
 
 
 
 is
predominant in activating PTKs (9–16).
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Ig
 
 
 
 ITAM Phosphorylation Mutant Mice
 
Aspects of Ig
 
 
 
 and Ig
 
 
 
 function in B cell development
were studied in transgenic and gene-targeted mice. In Ig
 
 
 
knockout mice, the lack of Ig
 
 
 
/Ig
 
 
 
 heterodimer forma-
tion presumably also abrogates the surface expression of
Ig
 
 
 
 and results in a complete block of development at the
pro-B cell stage (17). However, the expression of chimeric
molecules with cytoplasmic domains of either Ig
 
 
 
 or Ig
 
 
 
was capable of supporting further steps in B cell matura-
tion, including H chain allelic exclusion (18–20). Critical
roles of the cytoplasmic tails of Ig
 
 
 
 and Ig
 
 
 
 in B cell de-
velopment were revealed in 
 
mb-1
 
 
 
c/
 
 
 
c
 
 and 
 
Ig
 
 
 
 
 
c/
 
 
 
c
 
 mice
(21, 22). In 
 
Ig
 
 
 
 
 
c/
 
 
 
c
 
 mice, the cytoplasmic domain of Ig
 
 
 
is lacking, whereas in 
 
mb-1
 
 
 
c/
 
 
 
c
 
 mice (hereafter termed
 
Ig
 
 
 
 
 
c/
 
 
 
c
 
) a truncated Ig
 
 
 
 protein with a cytoplasmic domain
consisting of 20 instead of 61 amino acids is expressed. In
both mutants, B cell development is severely impaired re-
sulting in a drastic reduction of peripheral B lymphocyte
numbers. Functionally, the remaining B cells in the mu-
tants are unable of mounting a measurable immune re-
sponse against T cell–independent (TI) antigen. Further
experiments with 
 
Ig
 
 
 
 
 
c/
 
 
 
c
 
 mice revealed that the Ig
 
 
 
 cyto-
plasmic truncation causes enhanced negative selection of
autoreactive receptor specificities and generally renders
immature B cells more sensitive to antigenic contact.
Based on these data, an additional negative signaling func-
tion for Ig
 
 
 
 was suggested (23, 24).
To investigate the specific function of Ig
 
 
 
 ITAM phos-
phorylation in B cell development, we generated a mutant
mouse strain by gene targeting in which the Ig
 
 
 
 ITAM ty-
rosines were replaced with phenylalanines (
 
Ig
 
 
 
FF/FF
 
 mice).
 
Materials and Methods
 
Generation of Targeting Vector and Targeted Embryonic Stem Cell
Clones.
 
The 
 
mb-1
 
 targeting vector was designed as a replace-
ment vector (25). A loxP site was inserted into the Tth111I site of
intronIII. Intronic region and exons downstream of this loxP site
are exactly repeated 3
 
 
 
 to a floxed 
 
neo
 
r
 
 gene (see Fig. 1 A). Ty-
rosine to phenylalanine replacements within the ITAM were
achieved by site-directed mutagenesis (Tyr
 
182
 
: TAT to TTC;
Tyr
 
193
 
: TAT to TTT). An additional BamHI restriction site
within the 3
 
  
 
UTR, downstream of the mutated exons, was gen-
erated by an exchange of two nucleotides.
A 5.2-kb genomic BamHI fragment, containing the 
 
mb-1
 
gene, was recovered from a murine cosmid (C57BL/6J-pWE15
library; Stratagene; reference 26) and subcloned into the BamHI
site of pGEM-7Z
 
 
 
 (Promega) to generate pGEM5.2kbBamHI.
Subsequently, a 1.4-kb Tth111I–XhoI fragment was recovered
from this vector and subcloned into the EcoRI/XhoI sites of
pGEMloxP (unpublished data) to obtain pGEMloxPTth111I-XhoI.
Next, the Tth111I–PstI fragment of pGEM5.2kbBamHI was re-
placed with the NotI–PstI fragment from pGEMloxPTth111I-
XhoI to obtain pGEM5.2kbloxP. The 5.2-kb BamHI fragment
was then cloned into the BamHI site of pSL1190XX to obtain
pSL5.2kbloxP. pSL1190XX was generated from pSL1190 (Am-
ersham Pharmacia Biotech) by deleting the polylinker-region be-
tween XhoI and XbaI.
The region downstream of the 
 
mb-1
 
 polyA site was extended
0.4 kb by the following procedure. A 1.2-kb fragment was first
amplified by PCR from the genomic cosmid clone with the
primers 3
 
  
 
region-FOR (5
 
 
 
-CTGCCTCCCCACTCTTCC-3
 
 
 
)
and 3
 
  
 
region-REV (5
 
 
 
-CCATCGATCCTGCCGCGGCCGC-
TTACTCT-3
 
 
 
). This PCR product was subcloned into the
pCR™ TA Cloning vector II (Invitrogen), and a 1.2-kb EcoRI–
XhoI fragment was recovered. This fragment was used to replace
the 0.8-kb SmaI–XhoI fragment in pSL5.2kbloxP to obtain
pSL5.2kbloxP-3
 
 
 
. Next, pSL5.2kbloxP-3
 
 
 
 was cut with EcoRV–
XbaI and religated resulting in pSL5.2kbloxP-3
 
 
 
-
 
 
 
ClaI. Subse-
quently, the 
 
tk
 
 selection marker was excised as a HindIII fragment
from pIC-TK
 
 
 
Cla1, a modified version of pIC19R/MC1-TK
(26). This fragment was cloned into the HindIII site of
pSL5.2kbloxP-3
 
 
 
-
 
 
 
ClaI to obtain pSL5.2kbloxP-3
 
 
 
-
 
 
 
ClaI-TK.
For the construction of a loxP-flanked 
 
neo
 
r
 
 cassette, a SalI–XhoI
fragment was recovered from pMC1neoPolyA (Stratagene) and
cloned into the XhoI site of pGEMloxP to obtain pGEM-
neoloxP. From this vector, an XbaI–HindIII fragment was sub-
cloned into NotI–HindIII sites of pGEMloxP, resulting in pMM-
neoflox-8. A 1.2-kb XbaI–NsiI fragment from pMMneoflox-8
was cloned into Tth111I–NsiI–digested pGmb1C1C2
 
** 
 
(21) to
obtain pmb-1C1C2
 
**
 
neoflox. Additional restriction sites were
introduced by site-directed mutagenesis. The product of two
consecutive PCR reactions (primer: BamHI-FOR 5
 
 
 
-ATGT-
CTGGATCCAGCATCCC-3
 
 
 
; BamHI-REV 5
 
 
 
-GGGATGCT-
GGATCCAGACAT-3
 
 
 
; FLAG-C1C2
 
**
 
-FOR 5
 
 
 
-AACGGTG-
GCAAAATGAGAAG-3
 
 
 
; FLAG-C1C2
 
**
 
-REV 5
 
 
 
-TTGGGC-
CCCGATCGATCGCATG-3
 
 
 
) was subcloned into the pCR™
TA Cloning vector II (Invitrogen) and retrieved by digestion
with SalI and ApaI. The fragment was used to exchange the cor-
responding 1-kb fragment in pmb-1C1C2
 
**
 
neoflox to generate
pmb-1C1C2
 
**neoflox-BamHI.
Culturing and transfection of E14.1 embryonic stem (ES) cells
(129/Ola) was performed according to previously published pro-
tocols (27). Screening of 596 G418/gancyclovir double resistant
colonies by Southern blot analysis led to the identification of
three homologous recombinant ES cell clones (Fig. 1).
Mice. ES cells carrying the Ig FF-Flox allele were injected into
C57BL/6 and CB20 blastocysts which were then transferred into
foster mothers to obtain chimeric mice. Mice with the Ig FF-Flox
allele were crossed to the deleter-strain (28). Some analyses were
performed with Ig FF/FF mice of a mixed 129/Ola–C57BL/6 ge-
netic background. To control for a potential influence of the ge-
netic background (e.g., in immunization studies), control groups
of 129/Ola and C57BL/6 mice were included and analyzed in
parallel with the Ig FF/FF mice. In anti-phosphotyrosine immu-
noblotting experiments, all Ig FF/FF mice used had been back-
crossed for eight generations to C57BL/6. Ig  c/ c mice (22) are
of mixed 129/Sv–C57BL/6 genetic background. Ig  c/ c mice
(21) are of C57BL/6 genetic background. Ig FF/FFIg  C/ C mice
were generated by intercrossing Ig FF/FF mice to Ig  C/ C mice (22).
All mice, including Ig  C/ C (21) and JHT/JHT mice (29), were
housed in our conventional animal facility.
Preparation of Cell Suspensions from Lymphoid Organs. Spleens were
minced through a nylon mesh (cell strainer; Falcon) to obtain sin-
gle cell suspensions in DMEM, 5% FCS, and 2 mM l-glutamine.
Bones were flushed with medium to extract bone marrow (BM)
cells and the peritoneal cavity was flushed twice with 10 ml of
medium to recover cells. Erythrocytes were lysed from spleen and
BM preparations by incubating in lysis buffer (140 mM NH4Cl,
17 mM Tris-HCl, pH 7.65) for 2 min on ice. To obtain PBLs,
mice were bled from the tail vein in the presence of heparin (Liq-
uemin; Roche) and purified by gradient centrifugation with 7%
Ficoll 400 (Amersham Pharmacia Biotech).457 Kraus et al.
Figure 1. Generation of tar-
geted  Ig FF-flox/  ES cell clones
and Ig FF/FF mice. (A) Targeted
insertion of a loxP-flanked neor
gene, mutated cytoplasmic ex-
ons and a third loxP site into the
mb-1 locus, followed by the spe-
cific deletion of the neor selection
marker. The configurations of
the targeting vector (1), the
wild-type mb-1 locus (2), and the
targeted locus (3) after homolo-
gous recombination are shown.
Cre-mediated deletion of the neor
selection marker results in the
Ig FF-flox allele (4). In the mouse,
Cre-expression mediates the ex-
cision of the wild-type cytoplas-
mic exons to generate the mu-
tated Ig FF allele (5). Wild-type
exons are displayed as gray boxes,
whereas black boxes represent
the mutated exons. The tyrosine
encoding triplets in the ITAM
are indicated as YY, whereas the
mutated ITAM is highlighted by
FF. The white box shows the 3 
UTR, and boxes with a triangle represent loxP sites. Arrows underneath the targeting construct indicate the direction of transcription in the selection
marker genes. The map is drawn to scale except for the loxP sites and displays the following restriction sites: B, BamHI; C, ClaI; H, HindIII; N, NotI; T,
Tth111I. An asterisk marks the additional BamHI restriction site in the 3  UTR of the mutated cytoplasmic exons. The external probe used to verify the
targeting event is indicated together with the expected sizes of the restriction fragments. (B) Southern blot analysis of ES cell clones after transfection with
the targeting construct. Genomic DNA was digested with HindIII and hybridized with the 5  external probe. The targeted ES cell clone 3-D7, with the
characteristic band of 10.8 kb, is shown in comparison to a clone that possesses only the wild-type mb-1 locus ( / ). (C) Southern blot analysis of tar-
geted, G418 sensitive ES cell clones after transient Cre expression. Genomic DNA was digested with either HindIII or BamHI and hybridized with the 5 
external probe. ES cell clones with specific neor deletion (3-F5, 4-E5) show a characteristic band of 9.6 kb after HindIII digestion. Complete deletion of all
loxP flanked sequences is characterized by the presence of a 4.4-kb fragment after BamHI digestion (5-A4). For comparison, the parental G418 resistant
clone 3-D7 is included in the HindIII based analysis. (D) Southern blot analysis with the 5  external probe of BamHI digested genomic DNA from
Ig FF/FF and wild-type (wt) mice. (E) Sequence analysis of the Ig  ITAM in Ig FF/FF mice. Genomic DNA was extracted from purified splenic B cells of
Ig FF/FF and wild-type mice. Triplets encoding for the amino acids of the consensus ITAM sequence are underlined and the respective amino acid is indi-
cated. Intronic sequence is not shown (gap). The positions of the two non-ITAM Ig  tyrosines are indicated by a gray Y.458 Ig  ITAM Phosphorylation Mutant Mice
Flow Cytometry. Cells were surface stained with combinations
of FITC, PE, Cy-Chrome (Cyc), peridinine chlorophyll protein
(PERCP), and/or allophycocyanin (APC)-conjugated mono-
clonal antibodies for 20 min on ice. Stainings with biotinylated
monoclonal antibodies were followed by a secondary staining with
either Streptavidin-Cy-Chrome (BD PharMingen) or Streptavi-
din-PERCP (Becton Dickinson). After staining, the samples were
washed and resuspended with PBS, 1% BSA, and 0.01% N3.
Stained cells were acquired on a FACScan™ or FACSCalibur™
and data were analyzed using CELLQuest™ software (Becton
Dickinson). Dead cells were labeled with propidium iodide or
Topro-3 (Molecular Probes) and excluded from the analysis.
For intracellular Ig  chain staining, cells were first washed in
PBS then fixed in a 2% formaldehyde solution for 30 min at
room temperature (RT). After three washes with PBS, the cells
were stained for 20 min at RT with antibody M41 in 0.05% Sa-
ponin in PBS. Monoclonal antibodies R33–24.12 (anti-IgM),
1.3–5  (anti-IgD), RA3–6B2 (anti-B220), M41 (anti-  chain),
LS.136 (anti- 1), Cy34.1 (anti-CD22), M5/114 (anti-MHC class
II), BP-1 (anti-BP-1), 30F1 (anti-HSA), and Cfo1 (anti-Thy1.2)
were prepared and conjugated in our laboratory. Monoclonal an-
tibodies to CD5, CD19, CD21/CD35, CD23, CD25, CD43,
CD69, and CD86 were purchased from BD PharMingen. Anti-
493 antibody was a gift from A. Rolink (Basel Institute of Immu-
nology, Basel, Switzerland).
Immunization and Serum Analysis. Mice were immunized
with 5 or 50  g of T cell–dependent (TD) antigen NP-CG
(4-hydroxy-3-nitrophenylacetyl chicken- -globulin) in alum in-
traperitoneally. Mice were boosted with 5  g/200  l of NP17-CG
without adjuvant. TI immune response was analyzed by intraperi-
toneal injections of 5  g/200  l of NP27-Ficoll. Mice were bled
before and after immunization from tail veins. Ig serum concen-
trations were determined by ELISA as described previously (30).
Affinities of IgG1 and   NP-specific antibodies were deter-
mined by calculating the association constant as described previ-
ously (31). Briefly, relative binding of serum antibodies to NP5-
BSA versus NP14-BSA was determined by ELISA in comparison
to anti-NP antibody standards of known affinity.
Measurement of Ca2  Mobilization. Spleen cells (5   106/ml)
were loaded with 2  M Indo-1 AM in RPMI, 2% FCS for 30
min at 37 C (Molecular Probes). Afterwards, the cells were
washed and stained with anti–B220-PE (RA3–6B2) monoclonal
antibody in RPMI at RT. Fluorescence ratios of Indo-1 emission
at 395/510 nm were measured by flow cytometry on a dual laser
FACStar™ (Becton Dickinson). Data acquisition was conducted
for 50 s without stimulus, followed by the addition of either
F(ab) 2 rabbit anti-mouse IgM G A fragments (Zymed Labora-
tories) or rabbit anti–mouse IgM G A antibodies (Zymed Lab-
oratories). Data was collected for 512 s and analyzed using
CELLQuest™ (Becton Dickinson) and FlowJo (TriStar) software.
Analysis of Protein Tyrosine Phosphorylation. CD19  B cell popu-
lations were purified from splenic cell suspensions by magnetic
beads (MACS; Miltenyi Biotec) according to the manufacturer’s
instructions. B lymphocytes were resuspended at 107 cells/ml in
RPMI and stimulated with F(ab) 2 rabbit anti–mouse IgM 
G A fragments (Zymed Laboratories) for various time periods at
37 C. The reactions were stopped by addition of ice cold lysis
buffer to a final concentration of 1% NP-40, 150 mM NaCl, 0.4
mM EDTA, 10 mM Tris-HCl, pH 8, 1  g/ml leupeptin, 1  g/ml
aprotinin, 1  g/ml  1-antitrypsin, 1 mM PMSF, 10 mM sodium
pyrophosphate, 2 mM Na3VO4, and 10 mM NaF. After incuba-
tion on ice for 10 min, lysates were cleared at 12,000 g for 5 min
at 4 C. Ig  was immunoprecipitated from cleared lysates with
anti-Ig  monoclonal antibody 172 directly coupled to Sepharose
beads. For the immunoprecipitation of Lyn or Syk, cleared ly-
sates were incubated with either rabbit polyclonal anti–mouse
Lyn (sc-15; Santa Cruz Biotechnology, Inc.) or rabbit polyclonal
anti–mouse Syk antibodies (13), respectively; followed by addi-
tion of protein G-Sepharose beads (Amersham Pharmacia Bio-
tech). Proteins were resolved by 10% SDS-PAGE, transferred to
polyvinylidine difluoride (PVDF) membrane (Millipore), and
immunoblotted with anti-phosphotyrosine antibody Py54 (Cal-
biochem), followed by horseradish peroxidase (HRP)-conju-
gated rat anti–mouse IgG (Amersham Pharmacia Biotech) and
developed by chemiluminescence (ECL; Amersham Pharmacia
Biotech). To determine the amount of protein loaded in each
lane, the same membranes were stripped and reprobed with ap-
propriate antibodies.
Results
Generation of Ig FF/FF Mice. To allow for conditional
mutation of the Ig  ITAM at different stages of B cell de-
velopment, two loxP sites flanking both cytoplasmic exons
were targeted into the mb-1 locus (floxed allele; Fig. 1 A,
4). Downstream of the 3  end of mb-1 gene, mutated cyto-
plasmic exons encoding phenylalanine instead of tyrosine
within the ITAM were inserted. Transfection of E14.1 ES
cells led to the identification of three homologous recom-
binant ES cell clones (Fig. 1 A, 3, and Fig. 1 B). One clone
(3-D7) was shown by PCR analysis to have cointegrated
the 5  loxP site and the ITAM mutations (data not shown).
To remove the floxed neor selection cassette from the tar-
geted mb-1 allele, the clone was transiently transfected with
circular pICcre plasmid (29). Resulting G418-sensitive ES
cell clones were screened by Southern blot (Fig. 1 C) and
PCR analysis (not shown) to distinguish clones that carry
the Ig FF-flox floxed allele (Fig. 1 A, 4) from clones where
Cre-mediated recombination led also to the loss of the un-
mutated cytoplasmic exons (Ig FF mutated allele; Fig. 1
A, 5). ES cells carrying the Ig FF-flox allele were injected
into mouse blastocysts to generate chimeras that subse-
quently transmitted the floxed allele through the germline.
Ig FF-flox/  mice were bred with the deleter mouse strain (28)
to obtain Ig FF/  mice that were then bred to homozygos-
ity. The tyrosine to phenylalanine exchanges in the Ig 
ITAM were verified by sequencing. DNA for this analysis
was prepared from FACS®-sorted splenic B cells of Ig FF/FF
and wild-type control mice (Fig. 1 E).
B Cell Development in Ig FF/FF Mice. The requirement
of Ig  ITAM phosphorylation for B cell development was
analyzed in Ig FF/FF mice by flow cytometry (32). In con-
trast to Ig  c/ c mice, which have reduced fractions of pre-
B and immature B cells, Ig FF/FF mice had normal numbers
of pro-B (B220lowCD43 IgM ), pre-B (B220lowCD43 IgM ),
and immature B (B220lowIgM IgD ) cells in the BM (Fig.
2 A, and Table I). Similarly, the earliest stages of B cell de-
velopment within the pro-B cell compartment, fractions A
to C , were not blocked in Ig FF/FF mice (see Fig. 5). In
addition, a striking difference exists between mature B cells
in Ig  c/ c and Ig FF/FF mutants. Whereas recirculating B459 Kraus et al.
cells in the BM and splenic B cells were  100-fold re-
duced in the former, B cell numbers in Ig FF/FF mice were
only marginally reduced in comparison to wild-type mice
(Table I; Fig. 2, A and B). We analyzed the peripheral B
cells in Ig FF/FF mice for the expression of several surface
markers to determine their maturation and activation sta-
tus. As in wild-type controls, splenic B cells from ITAM
mutants were CD43  and  20% of them stained brightly
Figure 2. Altered distribution of B cell subpopulations in Ig FF/FF mice. Representa-
tive analyses of B cell development in Ig FF/FF mice by flow cytometry. (A) Comparison
of BM B cells of wild-type (wt), Ig  c/ c, and Ig FF/FF mice. In the IgM vs. B220 and the
IgD vs. IgM dot plots, numbers show the percentage of cells in the lymphocyte gate that
fall into the indicated windows. In the CD43 vs. B220 dot plots, only IgM B220  pro-
and pre-B cells are displayed to allow a comparison of their relative population sizes.
Numbers represent the fraction of pro-B cells as percentage of the gated cells. (B) Analy-
sis of spleen lymphocytes for the surface expression of IgM and IgD. The frequency of
the cells in the windows is shown as percentage of cells within the lymphocyte gate. (C)
Differences in IgM surface expression levels of CD19  spleen B cells from Ig FF/FF,
Ig  c/ c, and wild-type mice are directly compared in a histogram. IgD and CD19 surface
expression levels of spleen lymphocytes of Ig FF/FF mice are shown in comparison to
wild-type controls. (D) Analysis of spleen cells to determine the fraction of MZ B lymphocytes. Shown are CD19  spleen B lymphocytes; numbers repre-
sent CD21highCD23low cells from wild-type (9.9%   6.0, n   4; average   SD) and Ig FF/FF mice (2.1%   1.5; n   5). (E) Fraction of CD19  spleen B
lymphocytes expressing a  1 light chain. (F) Analysis of peritoneal lymphocytes in Ig FF/FF mice. In the IgM vs. CD5 dot plot, cells with the forward and
side scatter characteristics of lymphocytes are shown. T cells (IgM CD5 ): wt 12.3%   7.3, n   10; Ig FF/FF 21.7%   10.6, n   12. B cells (IgM CD5 ):
wt 35.5%   11.6, n   10; Ig FF/FF 3.7%   1.6, n   12. (IgM CD5 ): wt 38.1%   12.5, n   10; Ig FF/FF 51.7%   21.5, n   12. Percentages given are
averages   SD. The other dot plots present surface expression levels of CD19  peritoneal B lymphocytes from Ig FF/FF and wild-type mice.460 Ig  ITAM Phosphorylation Mutant Mice
for immature B cell marker 493 (data not shown). Normal
surface expression of activation markers CD86 (B7.2),
CD69 (data not shown), and MHC class II (Table II) was
observed.
Like the Ig  c/ c mutant (21), Ig FF/FF mice displayed al-
lelic exclusion at the IgH locus as verified by the analysis of
IgH allotype heterozygous mutant animals (unpublished
data).
Alterations of Surface Receptor Expression Levels in Ig FF/FF
Mice. Although the lack of Ig  ITAM phosphorylation
apparently did not block the generation of a large pool of
mature B cells, it caused changes in the surface level ex-
pression of BCR and several coreceptors. Fig. 2 C shows a
comparison of the surface IgM levels in splenic B cells of
wild-type, Ig  c/ c, and Ig FF/FF mice. In contrast to the ex-
tremely low surface IgM levels of B cells in Ig  c/ c mice,
the Ig  ITAM mutation led to increased surface IgM lev-
els. In general, B cells from various lymphoid organs carry-
ing the Ig FF allele express on average more surface IgM
and IgD than B cells from control mice (Fig. 2, and Table
II). This applies also for B1 cells in the peritoneal cavity
(Fig. 2 F, and Table II). Furthermore, we consistently ob-
served slightly higher surface expression levels of CD19
(Fig. 2 C, and Table II) and lower surface levels of CD22
and B220 (Table II) in B cells obtained from Ig FF/FF com-
pared with wild-type mice.
Reduction of Marginal Zone and B1 B Cell Populations.
Are the differences in receptor expression levels sufficient
to compensate for the Ig  ITAM phosphorylation defi-
ciency and to allow for the normal generation of all periph-
eral B cell subsets? Three different main B cell subpopu-
lations have been described for the spleen: immature,
follicular, and marginal zone (MZ) B cells. MZ B cells are
large cells that are CD21brightCD23low and IgMhighIgDlow.
Analysis of Ig FF/FF mice revealed that this population was
reduced to 5–25% of wild-type controls (Fig. 2 D).
In the peritoneal cavity, B cell numbers, mainly CD5 
B1 cells, were drastically reduced in the Ig  ITAM mutant
mice (Fig. 2 F). B1 cells are phenotypically characterized as
IgMbrightIgDlow and express lower levels of surface B220.
Most B1 cells are also CD43  and CD23 . As shown in
Fig. 2 F, this fraction of peritoneal B cells was reduced in
Ig FF/FF mice and most remaining B cells resembled B2
cells in being B220bright, IgD , CD23 , and CD43 . Cor-
responding to the reduction of B1 cell numbers, the T cell
fraction (CD5 IgM ; Fig. 2 F) of peritoneal lymphocytes
was increased.
Table I. Relative Size of B Cell Fractions in BM and Spleen
BM (percentage of all cells)
Pro-B
(A–C)
Pre-B
(D)
Immature
(E)
Recirculating
(F)
Spleen
(  106)
wt (n   9) 2.4   0.8 8.9   3.0 5.4   0.9 7.2   2.4 27.7   5.1
Ig FF/FF (n   8) 3.0   1.0 7.7   2.3 5.8   1.5 4.3   1.7 23.0   4.6
Ig  c/ c (n   5) 5.0   0.4 0.82   0.18 0.54   0.07 0.03   0.01 0.21   0.12
Ig  c/ c (n   5) 4.8   1.7 4.7   2.5 4.6   2.2 0.22   0.07 0.82   0.61
Sizes of BM B cell fractions A to F are indicated as percentage of all live cells. The absolute number of splenic B cells is shown. Values represent the
mean   SD of the indicated number of analyzed mice.
Table II. Comparison of Relative Expression Levels of Various B 
Cell Surface Molecules in Wild-Type and Ig FF/FF Mice
Antigen B cell population
Surface expression in
Ig FF/FF mice relative to
wild-type (%   SD)
IgM BM IgM B220low 144.5   35.0 n   10 *
IgM B220high 248.2   58.6 n   15 **
Spleen 205.5   33.8 n   11 **
Blood 222.3   13.9 n   5 **
Peritoneum B1 cells 171.5   37.8 n   8 *
IgD BM 126.9   9.3 n   10 **
Spleen 132.6   12.0 n   11 **
Blood 127.9   17.7 n   5#
B220 BM Pre-B 99.2   5.4 n   4
IgM B220low 96.6   5.4 n   10
IgM B220high 91.1   6.0 n   12 **
Spleen 88.1   6.9 n   12 **
Blood 86.2   6.8 n   5#
CD19 Spleen 116.6   5.9 n   15 **
Blood 122.9   11.4 n   5 *
Peritoneum B1 cells 117.7   13.5 n   6#
CD22 Spleen 81.8   4.8 n   10 **
MHCII Spleen 102.0   28.8  n   5
The levels of surface expression were determined by comparing the
mean fluorescence intensities between B cells of wild-type (set as 100%)
and Ig FF/FF mice. Numbers represent the mean percentages (  SD)
based on the number of indicated analyses. In each single analysis,
samples from Ig FF/FF mutants and wild-type mice were analyzed in
parallel. The significance of difference was tested with the paired
Student’s t test. Asterisks indicate the determined P values: #P   0.05;
*P   0.01; **P   0.001.461 Kraus et al.
Higher Percentage of  1 Light Chain Expressing B Cells in
Ig /Ig  Mutants. As in the BM of Ig FF/FF mice, all B cell
fractions were present in normal numbers, the lack of Ig 
ITAM phosphorylation does not appear to impose a block
in early B cell development (Table I). However, the impact
of the ITAM mutation on the rearrangement and/or selec-
tion of Ig light chains is apparent from the distortion of the
ratio of   versus   light chain expressing B cells. Compared
with wild-type controls, Ig FF/FF mice possessed more  1
light chain expressing B cells (Table III, and Fig. 2 E). This
phenomenon could also be seen, and appeared even more
pronounced, in the cytoplasmic truncation mutants of Ig 
and Ig  (Table III).
Reduced IgG1 Serum Levels and Impaired TD Immune Re-
sponse in Ig FF/FF Mice. Altered BCR signaling in Ig FF/FF
mice may also affect immune responsiveness. To check
whether the ITAM mutation influences the basal levels of
Ig titers, Ig isotypes were determined by ELISA in the sera
of unimmmunized mice. As shown in Fig. 3 A, the total
amount of serum Ig in Ig FF/FF mice, calculated as a sum of
the individual isotypes, was comparable to controls. Al-
though B1 cells are thought to be the main contributors of
serum IgM, the reduction in B1 and MZ B cells in Ig 
ITAM mutants did not result in reduced serum IgM con-
centration. However, the serum concentration of IgG1 in
Ig FF/FF mice was significantly lower than in wild-type
controls.
To analyze humoral immune responses, we immunized
Ig FF/FF mice with the TI type II (TI-II) antigen NP-
Ficoll and TD antigen NP-CG. For two reasons we ex-
pected to see an impaired TI-II response. First, in Ig  c/ c
mice, B cells with a cytoplasmic truncation of Ig  were
unable to mount a measurable response toward NP-Ficoll
(21), and second, recent data suggest that MZ B cells are
required for a normal TI-II response (33). However, the
Table III. Fraction of  1 Light Chain Expressing Spleen B Cells 
in Ig  and Ig  Mutant Mice
wt 4.8   0.6% n   13
Ig FF/FF 10.9   3.1% n   10
Ig  c/ c 22.1   3.1% n   7
Ig  c/ c 20.4   5.8% n   4
The frequency of B cells expressing a  1 light chain was determined by
flow cytometry and is shown as percentage of all splenic B cells. Values
represent the mean   SD of the indicated numbers of mice.
Figure 3. Serum Ig levels and
humoral immune responses in
Ig FF/FF mice. Serum Ig isotype
levels were determined by
ELISA. Filled symbols represent
wild-type and open symbols rep-
resent  Ig FF/FF mice. (A) Geo-
metric means and standard devi-
ations of serum levels of Igs in
nonimmunized mice (n     5).
The data are representative of
three independent analyses. (B)
Immune response to TI-II NP-
Ficoll antigen. Plots show NP-
specific IgG3 in sera of mice af-
ter immunization with either 5
or 50  g NP-Ficoll. Crosses in-
dicate geometric mean values.
(C) Immune response to a TD
antigen. NP-specific IgG1 levels
in primary and secondary re-
sponses after immunizations with
5  g NP-CG were determined
in Ig FF/FF mice (n     5) and
wild-type (wt) controls (n   6).
Shown are geometric mean val-
ues plus standard deviation. As-
terisks indicate P  values that
were calculated according to the
Student’s t test. (D) Affinity mat-
uration of anti-NP IgG1 in sera
of Ig FF/FF and control mice. Af-
finities on day 14 after a primary
and on day 11 after a secondary
immunization with 5  g NP-
CG are shown.462 Ig  ITAM Phosphorylation Mutant Mice
NP-specific serum titers at different time points after the
immunization revealed that Ig  ITAM phosphorylation is
not required for an efficient TI-II response (Fig. 3 B).
Ig FF/FF mice were also able to mount primary and sec-
ondary TD responses, which had a kinetics comparable to
those of wild-type controls (Fig. 3 C). These data imply
that Ig  ITAM phosphorylation is not a prerequisite for B
cell memory formation. However, the TD response was
significantly lower in Ig FF/FF mice at all time points ex-
amined (Fig. 3 C). To evaluate further the efficiency of
the TD response, we determined the averaged relative af-
finity of the serum antibodies. Affinities of NP-specific an-
tibodies were comparable between Ig FF/FF mice and con-
trol groups, and were equally increased in the course of
the immune response, indicating effective affinity matura-
tion (Fig. 3 D).
Stronger Calcium Response in Ig  ITAM Mutant B Cells. To
analyze the impact of the ITAM mutation on an early
BCR-mediated signaling event, we stimulated Indo-1–
loaded B cells either with F(ab) 2 fragment of anti-Ig anti-
body or with anti-Ig antibodies and monitored changes in
intracellular calcium by flow cytometry. Previously, we re-
ported that a cytoplasmic truncation of Ig  leads to an ele-
vated and more sustained calcium response in immature B
cells of Ig  c/ cIgHEL mice compared with controls (23). We
show here that this effect appears to be correlated with the
phosphorylation of the Ig  ITAM, as splenic B cells from
Ig FF/FF mice also showed a stronger calcium response with
a delayed maximum in comparison to wild-type controls
(Fig. 4, and data not shown).
BCR Ligation Leads to Tyrosine Phosphorylation of Ig  in
Ig FF/FF B Cells. To extend the analysis of the signaling
capacity of Ig  ITAM mutant BCRs, we analyzed protein
tyrosine phosphorylation after BCR cross-linking. Splenic
B cells were isolated from Ig FF/FF and control mice, and
stimulated with F(ab) 2 fragment of anti-Ig antibody for
different time durations. Total protein tyrosine phosphory-
lation was revealed by anti-phosphotyrosine immunoblot-
ting. As shown in Fig. 5 A, BCRs lacking the Ig  ITAM
tyrosines were still capable of inducing protein tyrosine
phosphorylation to levels comparable to controls. We then
specifically examined the tyrosine phosphorylation of Ig 
and Ig  in anti-Ig  immunoprecipitates before and after
BCR cross-linking. As shown in Fig. 5 B, BCR ligation of
Ig FF/FF B cells resulted in a rapid and persistent tyrosine
phosphorylation of Ig  ITAM. Moreover, BCR-induced
tyrosine phosphorylation of Ig  in Ig FF/FF mice was en-
hanced compared with controls (Fig. 5, A and B). Whereas
Ig  possesses only the two tyrosines of its ITAM, the cyto-
plasmic tail of Ig  contains four tyrosine residues (Fig. 1 E).
Interestingly, Ig  phosphorylation in Ig  ITAM mutant B
cells was detected after BCR ligation (Fig. 5 B). These data
suggest that either one or both non-ITAM Ig  tyrosine
residues (#176 and #204) can be phosphorylated after
Figure 4. Comparison of BCR-induced Ca2  mobilization. Changes in intracellular calcium levels were determined by flow cytometry. Dot plots
present the intracellular calcium levels in B220  gated splenic B cells as the fluorescence ratio of Indo-1 emission at 395/510 nm recorded over time.
Baseline fluorescence ratios were acquired for 50 s before F(ab) 2 rabbit anti–mouse Ig antibodies were added (indicated by an arrow). Final antibody
concentrations are shown on the right. Histograms on the right show the median values of the analyzed B cells. Results are representative of four inde-
pendent experiments. wt, wild-type.463 Kraus et al.
BCR stimulation. This strongly suggests a role for the non-
ITAM tyrosines in BCR-mediated signaling, e.g., as a
binding site for SH2 domain containing proteins.
Syk kinase is one of the major signaling components that
binds to doubly phosphorylated BCR ITAMs and becomes
activated. Ligation of BCRs with the mutant Ig  ITAM
were still able to induce Syk tyrosine phosphorylation, pre-
sumably via phosphorylated Ig . However, maximum
phosphorylation was reached at a later time point than in
wild-type controls (Fig. 5C). Examination of Lyn phos-
phorylation showed that basal tyrosine phosphorylation was
similar between Ig FF/FF and wild-type B cells, but BCR-
induced Lyn tyrosine phosphorylation was less than in
wild-type controls (Fig. 5 D).
Complete Block of B Cell Development in Ig FF/FFIg  c/ c
Mice. Targeted mutations of Ig , as in truncation of the
cytoplasmic tail in Ig  c/ c mice (21) or with specific loss of
ITAM phosphorylation in Ig FF/FF mice, lead to alteration
in development and responsiveness of B lymphocytes. Sim-
ilarly, a cytoplasmic truncation of Ig  in Ig  c/ c mice com-
promises B cell development and causes a strong reduction
in mature B cells (22; Fig. 6). However, neither the lack of
Ig  nor Ig  ITAM alone leads to a complete block in B
cell development. A cytoplasmic domain of either Ig  or
Ig  is still sufficient to signal (22). Based on the phenotypic
differences between Ig  c/ c and Ig FF/FF mice and the find-
ing that Ig  may be phosphorylated at non-ITAM ty-
rosines, Ig  may not mediate signaling exclusively through
its phosphorylated ITAM. Whether development of B cells
in the Ig  and Ig  truncation mutants was absolutely de-
pendent on the phosphorylation of the remaining BCR
ITAM remained unclear. To answer this question, we gen-
erated  Ig FF/FFIg  c/ c mice. In comparison to Ig  c/ c
mice, the double mutants possessed no intact ITAM. As
shown in Fig. 6 A, B cell development in these mice
was completely blocked at the pro-B cell stage, as no
B220 CD43  B cells were present in the BM. FACS®
analysis of the B220 CD43  pro-B cell fraction revealed
the presence of fractions A to C, but fraction C  (BP-
1 HSAbright) was absent (Fig. 6 B). In the periphery of
Ig FF/FFIg  c/ c mice, a few CD19  cells were still detect-
able (Fig. 6 C), however, these cells did not express surface
IgM nor IgD. These CD19  cells expressed the immature
B cell marker 493 and had low levels of surface CD19 and
B220 (data not shown). Thus, these cells might represent
peripheral B cell precursors. The lack of any functional ma-
ture B cells in Ig FF/FFIg  c/ c mice was further validated by
the absence of any detectable serum Igs (data not shown).
Collectively, these data indicate an absolute requirement of
Ig  ITAM phosphorylation in Ig  c/ c mice for B cells to
develop beyond the pro-B cell stage.
Discussion
Ig  ITAM Mutation Affects B Cell Development Less Dra-
matically than Truncation of the Ig  Cytoplasmic Tail. The B
cell antigen receptor complex relies on its Ig /Ig  het-
erodimer for surface expression, internalization, antigen
presentation, and signaling. Therefore, a targeted ablation
of the cytoplasmic effector domain of either Ig  or Ig 
may result in impaired B cell development and function.
This is indeed evident in both Ig  c/ c and Ig  c/ c mice
which exhibit a drastic reduction in peripheral B cell num-
bers (21, 22). To date, the main signaling function of the
Ig /Ig  heterodimer has been ascribed to its two ITAMs.
Figure 5. Analysis of protein tyrosine
phosphorylation in splenic B cells of Ig FF/FF
mice. Cell lysates of purified splenic B cells
from Ig FF/FF and wild-type mice were pre-
pared from cells that were either mock stimu-
lated with medium or stimulated with 5  g/
106 cells F(ab) 2 rabbit anti–mouse Ig for dif-
ferent periods of time. (A) Tyrosine phos-
phorylation of total cellular proteins (5   105
cells/lane) was detected by anti-phosphoty-
rosine immunoblotting. Arrows indicate the
expected positions of Ig  and Ig . (B) Phos-
photyrosine immunoblot of Ig  immunopre-
cipitates. The bottom panel shows the same
blot reprobed with an anti-Ig  antibody. (C)
Syk tyrosine phosphorylation. Proteins were
immunoprecipitated from the cell lysates with
anti-Syk antibody, resolved by SDS-PAGE,
and analyzed by anti-phosphotyrosine immu-
noblotting. The blot was reprobed with anti-
Syk antibody. (D) Phosphotyrosine immuno-
blot of Lyn immunoprecipitates. The blot was
reprobed with anti-Lyn antibody.464 Ig  ITAM Phosphorylation Mutant Mice
Moreover, mutational experiments in cell lines have re-
vealed that ITAM functions require phosphorylation at its
two tyrosine residues (9, 10, 13, 14, 16, 34). However, the
present analysis of Ig FF/FF mice revealed striking differ-
ences in comparison to Ig  c/ c mice. A lack of Ig  ITAM
phosphorylation did not affect the relative fraction sizes of
pro-B, pre-B, and immature B cells in the BM, and the ab-
solute splenic B cell numbers in Ig FF/FF mice were compa-
rable to those of wild-type controls. Taken together, the
differences in phenotypes resulting from either the loss of
the Ig  cytoplasmic tail or the specific lack of Ig  ITAM
phosphorylation, imply a role for the non-phosphorylated
ITAM and/or other parts of the Ig  cytoplasmic tail in
Ig -mediated function. This idea is consistent with the
finding that Ig  ITAM phosphorylation is not a prerequi-
site for binding of Src family kinases Lyn and Fyn via their
N-terminal regions (35) and in agreement with the model
that proposes a high affinity, phosphotyrosine-dependent,
and a low affinity, phosphotyrosine-independent associa-
tion of Src family kinases with Ig /Ig  (36). In addition,
the Ig  molecules in Ig  c/ c mice lack the serine/threo-
nine phosphorylation sites which are implicated in the reg-
ulation of Ig  tyrosine phosphorylation (37). Thus, differ-
ences in serine/threonine phosphorylation might also be
responsible for the phenotypic differences of Ig  c/ c and
Ig FF/FF mice. Alternatively, lack of the Ig  cytoplasmic
domain in Ig  c/ c mice might influence the structure of
the remaining Ig  tail and distort its ITAM function. The
different phenotype of Ig FF/FF mice could thus also reflect
a difference in Ig  ITAM function.
Altered Surface Antigen Expression in B Cells of Ig FF/FF
Mice Due to Adaptation or Selection. B cells from Ig FF/FF mice
express higher levels of surface IgM and IgD compared
with wild-type controls. Three reasons might account for
the higher BCR density. First, lack of efficient protein-
kinase activation via phosphorylated Ig  ITAMs might be
partly compensated by expressing more Ig /Ig  on the cell
surface. Second, the increase in Ig  ITAM phosphorylation
Figure 6. Complete block of B cell development at the pro-B cell stage in the absence of any phosphorylatable BCR ITAM. Representative flow
cytometric analyses of lymphocytes from wild-type, Ig FF/FF, Ig  c/ c, and Ig FF/FFIg  c/ c mice. (A) Note the lack of CD43  B cells in the BM of Ig FF/FF
Ig  c/ c mice. (B) The HSA vs. BP-1 dot plots show CD43 B220  gated pro-B cells. Numbers indicate the frequency of cells within the windows as
percentage of the displayed pro-B cells. (C) CD19 and Thy1.2 surface expression of splenic lymphocytes. Fractions of B and T cells are shown as
percentage of cells in the lymphocyte gate.465 Kraus et al.
might partially substitute for the lack of Ig  ITAM phos-
phorylation. Third, Ig  ITAM phosphorylation might di-
rectly control BCR surface expression or internalization.
The latter possibility is supported by the analysis of Ig 
mutant molecules in cell cultures. While in reconstitution
experiments using the J558L m cell line, neither a cyto-
plasmic deletion nor Ig ITAM tyrosine mutations inter-
fered with the surface expression of BCR (10), constitutive
receptor endocytosis appeared to be dependent on the cy-
toplasmic tail of Ig  in a chimeric system (38). Similarly,
analyzing Fc RII-Ig  or Ig  chimeric molecules in the
A20/IIA1.6 cell line, efficient constitutive BCR internal-
ization was only mediated by the cytoplasmic domain of
Ig  and was shown to be dependent on the first Ig  ITAM
tyrosine (38).
Interestingly, B cells in Ig  c/ c mice do not exhibit a
similar increase in surface BCR expression levels as in
Ig FF/FF mice, and the cytoplasmic truncation of Ig  in
Ig  c/ c mice leads to lowered BCR expression (22; Fig. 2,
B and C). One might speculate that surface BCR expres-
sion levels are controlled by constitutive Ig /Ig -depen-
dent turnover mechanisms and in addition are adjusted to
the specific signaling requirements of the B cells.
In line with the idea that Ig  ITAM phosphorylation is
required for efficient activation of Src family kinases are the
observations of an increased CD19 and a decreased CD22
coreceptor surface expression in B cells from Ig FF/FF mice.
CD19 was shown to lower the threshold of BCR-mediated
cell activation and to be involved in the activation of Src
family kinases (39, 40). In contrast, CD22 contains immu-
noreceptor tyrosine-based inhibitory motifs (ITIMs) which
serve as docking sites for SH2 domain-containing phospho-
tyrosine phosphatase (SHP)-1, and thus might serve to
lower protein kinase activity (41–43). Interestingly, B cells
in CD22-deficient mice (44, 45) and transgenic mice over-
expressing CD19 (46) possess decreased surface IgM levels.
Thus, differences in BCR and coreceptor surface expres-
sion levels in Ig FF/FF mice might be the result of selection
and/or adaptation of B cells, in an attempt to cope with
weakened intrinsic BCR signaling. To address the issue
of selection versus adaptation, we plan to analyze
Ig FF-flox/FF-flox mice in combination with inducible or
developmental stage specific Cre-recombinase expression
(47). The floxed Ig  allele (Fig. 1 A, 4) allows undisturbed
B cell development with a wild-type BCR until Cre-medi-
ated mutation of the Ig  ITAM occurs. Induced mutagen-
esis should thus allow us to study the adaptive response of
mature B cells to a lack of Ig  ITAM phosphorylation.
PTK Activation by Ig  ITAM and Non-ITAM Tyrosine
Phosphorylation. Previous studies with B cell lines have
implied a critical requirement for Ig  ITAM tyrosine phos-
phorylation in the activation of PTKs after BCR ligation
(9, 10, 13, 48). However, in some initial signaling studies
with splenic B cells of Ig FF/FF mice we did not observe a
drastic reduction in overall protein tyrosine phosphoryla-
tion after BCR cross-linking, which could be explained by
the presence of a functional Ig  ITAM. Overall higher sur-
face expression and more efficient ITAM phosphorylation
of Ig  might thus be able to compensate in part for the lack
of Ig  ITAM phosphorylation in Ig FF/FF B cells. We
tested the capability of Syk and Lyn to undergo tyrosine
phosphorylation upon BCR ligation in B cells of Ig FF/FF
mice. Although Ig  ITAM phosphorylation is not abso-
lutely required to induce tyrosine phosphorylation of Syk,
the overall Syk tyrosine phosphorylation was lower and de-
layed as a result of the Ig  ITAM mutation. Similarly, Lyn
was inducibly tyrosine phosphorylated in Ig FF/FF B cells,
but to a lesser extent than in controls. An important novel
finding is the demonstration of Ig  tyrosine phosphoryla-
tion apart from its ITAM. This suggests an involvement of
the Ig  non-ITAM tyrosines in BCR-dependent signaling.
These might recruit distinct signaling proteins or alterna-
tively enhance or inhibit the association of molecules with
the Ig /Ig  heterodimer. Both non-ITAM tyrosines are
indeed in the sequence context of a potential Src family
SH2 domain binding site (49, 50). Compared with wild-
type controls, the weak tyrosine phosphorylation of Ig  in
Ig FF/FF B cells supports the idea that the ITAM tyrosines
are the main tyrosine phosphorylation sites in Ig  (10).
However, in the wild-type situation, phosphorylation of
the non-ITAM tyrosines could well be linked to and de-
pendent on Ig  ITAM phosphorylation. A clarification of
these matters will require a biochemical analysis which is
beyond the scope of this paper.
Ig  ITAM Phosphorylation and Ca2  Mobilization. The
enhanced Ca2 -flux in B cells of Ig FF/FF mice after BCR
ligation seems to contradict the idea that Ig  ITAM phos-
phorylation functions to amplify signaling. Previous trans-
fection experiments with Fc RII-Ig  or Fc RII-Ig  chi-
meric molecules in the IIA1.6 cell line demonstrated that
only the Ig  cytoplasmic tail was capable to mobilize Ca2 
from intracellular stores and influx of extracellular calcium.
In contrast, the Ig  cytoplasmic domain stimulated only an
oscillatory release from intracellular stores, which overall
resulted in a small increase of free intracellular Ca2  (9, 51).
Further analyses specified an absolute requirement of the
proximal Ig  ITAM tyrosine (Y182) for Ca2  mobilization
(9, 13). Thus, it was surprising to find an even stronger
Ca2  mobilization in splenic B cells of Ig FF/FF mice after
BCR ligation (Fig. 4). One might interpret the data such
that Ig  ITAM phosphorylation is required to contain and
terminate Ca2  mobilization. While the increased Ca2 
mobilization in B cells of Ig FF/FF mice is not caused by
overall higher surface BCR expression (data not shown),
changes of coreceptor expression might influence the out-
come of BCR ligation by resetting signaling thresholds. In
support of the latter, overexpression of CD19 (46) or lack
of CD22 (44, 45, 52, 53) in mouse B cells also leads to en-
hanced calcium mobilization, whereas the lack of CD19
lowers it (54).
Ig /Ig  Mutations Distort Light Chain Rearrangements.
Although we do not yet know whether the Ig  ITAM
mutation leads to enhanced editing of autoreactive BCRs
like the Ig  truncation (23), it is noteworthy that both mu-
tations distort the   to   ratio in favor of   light chain ex-
pression. One might speculate that quantitative and qualita-466 Ig  ITAM Phosphorylation Mutant Mice
tive alterations of signals transmitted by a mutant Ig /Ig 
complex might hinder the efficient termination of light
chain rearrangements in B cell development, widening the
time window in which sequential rearrangements in the
light chain loci occur and thus driving more cells to the  
chain expression, if   rearrangements usually preceed   re-
arrangements (55). In line with this interpretation are the
observations that the shift in favor of   chain expression is
more pronounced in the tail truncation mutants than in
Ig FF/FF mice and that only in the former mutants there is
an apparent block of B cell development at the immature B
cell stage. Alternatively, altered pre-BCR signaling might
influence the order of light chain gene rearrangements and
cause an earlier opening of the   locus. In an extreme sce-
nario this could lead to the exclusive rearrangement of the
  locus in   chain–expressing cells. We tested this hypoth-
esis by analyzing the rearrangement status of the   loci in
 1  splenic B cells. However, similar to the situation in
 1  cells from wild-type mice (56), the   light chain loci
were found to be rearranged in  1  cells of Ig FF/FF mice
(data not shown). Finally, it might be possible that   light
chains confer a selective advantage for B cells in case of dis-
torted BCR signaling.
Dependence of B1 and MZ B Cell Populations on Ig  ITAM
Phosphorylation. In the peritoneal cavity of Ig FF/FF mice,
the total number of B cells was lower than in the wild-type
due to a drastic reduction in B1a cells. The majority of
the remaining peritoneal B cells were phenotypically B2
cells. B1 cells often express germline-encoded self-reactive
BCRs and appear to have signaling requirements that are
different from B2 cells (57). Recent studies have demon-
strated that the expression of an autoreactive receptor can
drive the generation of B1 cells (58, 59), suggesting that B1
cell development depends on signals mediated by BCR–
ligand interaction. The specific reduction of B1 cells in
Ig FF/FF mice could thus be explained by enhanced nega-
tive selection of autoreactive BCR specificities, but would
also be consistent with the idea that Ig  ITAM phosphory-
lation functions as a signal amplifier. In support of the latter
conclusion, several mouse mutants affecting genes involved
in positive regulation of BCR signaling such as CD19 (60,
61), Btk (62, 63), and Vav (64, 65) also show a reduction in
the B1 cell population. An opposing phenotype is seen
upon mutation of genes thought to negatively regulate
BCR-related signaling. SHP-1 deficiency in mev/mev mice
(66) and knockouts of CD22 (53, 45) and CD72 (67) all
lead to an expansion of the B1 cell population. This is also
true for mice in which the SHP-1 gene is selectively inacti-
vated in B cells (data not shown).
In the spleen of Ig FF/FF mice we observed a strong re-
duction of MZ B cells. Similar to the B1 population, MZ B
cell selection also depends on BCR specificities with a bias
for autoreactivity (68). Moreover, both B1 and MZ B cells
are CD23lowIgMhigh and larger in size than B2 cells. Theses
results demonstrate directly that appropriate BCR signaling
is required for the normal generation and maintenance of
both these subsets.
Ig  ITAM Phosphorylation Is Required for Efficient TD Im-
mune Responses. B1 and MZ B cells are thought to be the
frontline of an early defense against pathogens and appear
to be regulated in a T cell–independent way (69). In a re-
cent study of Pyk-2 knockout mice, which completely lack
MZ B cells, an important role for MZ B cells in T cell–inde-
pendent antibody responses was suggested (33). Therefore
and because TI-II responses have been shown to be se-
verely impaired in Ig  and Ig  tail truncation mutants
(21, 22), we expected an impairment of the anti-NP-Ficoll
response in Ig FF/FF mice. However, the selective elimina-
tion of the Ig  ITAM does apparently not interfere with
efficient B cell activation upon strong BCR cross-linking.
It is unclear at this point whether the difference between
the Ig  ITAM and the truncation mutants in this respect
reflects a difference in B cell activation or relates to the de-
velopment of B cell subsets which may be disturbed in the
mutants to different extents. That the Ig  ITAM mutation
is compatible with an intact TI-II response, but affects the
efficiency of a TD antibody response is consistent with the
findings in cell lines that Ig  ITAM tyrosines contribute to
efficient antigen presentation, but are not absolutely re-
quired for the presentation of multivalent antigens (48, 70,
71). Inefficient TD responses may also explain the low
IgG1 levels in the sera of Ig FF/FF mice.
Absolute Requirement of BCR ITAM Tyrosines for B Cell
Development Beyond the Pro-B Cell Stage. A striking obser-
vation is the absolute block of B cell development at the
pro-B cell stage in mice lacking the Ig  ITAM and the Ig 
cytoplasmic tail. This contrasts with an almost unimpaired
early B cell development in the Ig  ITAM mutant and sig-
nificant pre-B cell promotion in mice expressing a trun-
cated Ig  or Ig  chain. The simplest interpretation of these
results is that there is significant functional redundancy be-
tween the Ig  and Ig  ITAM (similar to that exhibited by
the ITAMs of the T cell receptor complex; reference 72),
and that there is an absolute requirement for the presence
of an ITAM in the pre-BCR at the pro- to pre-B cell tran-
sition which is known from earlier work to depend on pre-
BCR expression (17, 29, 73–75). It remains to be estab-
lished whether this requirement relates to pre-BCR surface
expression or more likely, the signaling function of the sur-
face bound receptor. The latter aspect is supported by pre-
vious findings showing a requirement of ITAM tyrosines
for pre-B cell development and allelic exclusion in trans-
genic systems using IgM/Ig  and IgM/Ig  chimeric recep-
tors (18–20). It will be interesting to determine whether
later stages of B cell development, where the BCR rather
than the pre-BCR plays a critical role (21, 76–78), exhibit
a similar ITAM dependence. Inducible targeted mutagene-
sis will be instrumental in resolving this issue.
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